Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT05739734
EARLY_PHASE1
Safety of CRIS100 on Treatment Spinal Cord Injury
Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.
Official title: Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2026-04
Completion Date
2027-05
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
CRIS100
local application of CRIS100